DD angiotensin-converting enzyme gene polymorphism is associated with endothelial dysfunction in normal humans

Robert Butler, Andrew D. Morris, Brian Burchell, Allan D Struthers

    Research output: Contribution to journalArticle

    90 Citations (Scopus)

    Abstract

    A polymorphism within the angiotensin-converting enzyme (ACE) gene may increase the risk of myocardial infarction in individuals previously thought to be at low cardiovascular risk. The mechanism through which it exerts this effect is unknown but may be due to increased angiotensin II-induced nitric oxide (NO) breakdown and/or reduced bradykinin-mediated NO release. We investigated whether endothelial function was different between different ACE genotypes. We performed a cross-sectional study comparing the endothelial function of the 3 genotypes (II: n=25; ID: n=31; DD: n=12). Mean+/-SD ages of the subjects were 24+/-4 (II), 25+/-6 (ID), and 25+/-6 (DD) years. We assessed the impact of the genotypes on endothelial function and found that the DD genotype was associated with a significant blunting in endothelial-dependent vasodilatation (forearm blood flow data are presented as mean+/-SD ratio of blood flow in response to 3 incrementally increasing doses of each vasoactive agent in the test arm to blood flow in the control arm; the comparison is between DD versus ID versus II; the P value is an expression of an overall difference by ANOVA, and the 95% CIs are of a pairwise comparison between genotypes): acetylcholine, 2.88+/-1.45 versus 3.81+/-1.93 versus 4.23+/-2.37 (P=0.002; 95% CI [II versus ID], -0.19 to 0.91; 95% CI [II versus DD], 0.36 to 1.80; 95% CI [ID versus DD], 0.02 to 1.42). There was also a significant difference with the endothelial-independent vasodilator sodium nitroprusside, with values of 2.11+/-1.00 versus 2.55+/-1.36 versus 2.75+/-1.18 (P
    Original languageEnglish
    Pages (from-to)1164-8
    Number of pages5
    JournalHypertension
    Volume33
    Issue number5
    DOIs
    Publication statusPublished - 1999

    Fingerprint

    Peptidyl-Dipeptidase A
    Genotype
    Genes
    Nitric Oxide
    Arm
    Nitroprusside
    Bradykinin
    Vasodilator Agents
    Forearm
    Vasodilation
    Angiotensin II
    Acetylcholine
    Analysis of Variance
    Cross-Sectional Studies
    Myocardial Infarction

    Cite this

    Butler, Robert ; Morris, Andrew D. ; Burchell, Brian ; Struthers, Allan D. / DD angiotensin-converting enzyme gene polymorphism is associated with endothelial dysfunction in normal humans. In: Hypertension. 1999 ; Vol. 33, No. 5. pp. 1164-8.
    @article{bbae1f84f97843abbdb71794fb4ce1c9,
    title = "DD angiotensin-converting enzyme gene polymorphism is associated with endothelial dysfunction in normal humans",
    abstract = "A polymorphism within the angiotensin-converting enzyme (ACE) gene may increase the risk of myocardial infarction in individuals previously thought to be at low cardiovascular risk. The mechanism through which it exerts this effect is unknown but may be due to increased angiotensin II-induced nitric oxide (NO) breakdown and/or reduced bradykinin-mediated NO release. We investigated whether endothelial function was different between different ACE genotypes. We performed a cross-sectional study comparing the endothelial function of the 3 genotypes (II: n=25; ID: n=31; DD: n=12). Mean+/-SD ages of the subjects were 24+/-4 (II), 25+/-6 (ID), and 25+/-6 (DD) years. We assessed the impact of the genotypes on endothelial function and found that the DD genotype was associated with a significant blunting in endothelial-dependent vasodilatation (forearm blood flow data are presented as mean+/-SD ratio of blood flow in response to 3 incrementally increasing doses of each vasoactive agent in the test arm to blood flow in the control arm; the comparison is between DD versus ID versus II; the P value is an expression of an overall difference by ANOVA, and the 95{\%} CIs are of a pairwise comparison between genotypes): acetylcholine, 2.88+/-1.45 versus 3.81+/-1.93 versus 4.23+/-2.37 (P=0.002; 95{\%} CI [II versus ID], -0.19 to 0.91; 95{\%} CI [II versus DD], 0.36 to 1.80; 95{\%} CI [ID versus DD], 0.02 to 1.42). There was also a significant difference with the endothelial-independent vasodilator sodium nitroprusside, with values of 2.11+/-1.00 versus 2.55+/-1.36 versus 2.75+/-1.18 (P",
    author = "Robert Butler and Morris, {Andrew D.} and Brian Burchell and Struthers, {Allan D}",
    year = "1999",
    doi = "10.1161/01.hyp.33.5.1164",
    language = "English",
    volume = "33",
    pages = "1164--8",
    journal = "Hypertension",
    issn = "0194-911X",
    publisher = "American Heart Association",
    number = "5",

    }

    DD angiotensin-converting enzyme gene polymorphism is associated with endothelial dysfunction in normal humans. / Butler, Robert; Morris, Andrew D.; Burchell, Brian; Struthers, Allan D.

    In: Hypertension, Vol. 33, No. 5, 1999, p. 1164-8.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - DD angiotensin-converting enzyme gene polymorphism is associated with endothelial dysfunction in normal humans

    AU - Butler, Robert

    AU - Morris, Andrew D.

    AU - Burchell, Brian

    AU - Struthers, Allan D

    PY - 1999

    Y1 - 1999

    N2 - A polymorphism within the angiotensin-converting enzyme (ACE) gene may increase the risk of myocardial infarction in individuals previously thought to be at low cardiovascular risk. The mechanism through which it exerts this effect is unknown but may be due to increased angiotensin II-induced nitric oxide (NO) breakdown and/or reduced bradykinin-mediated NO release. We investigated whether endothelial function was different between different ACE genotypes. We performed a cross-sectional study comparing the endothelial function of the 3 genotypes (II: n=25; ID: n=31; DD: n=12). Mean+/-SD ages of the subjects were 24+/-4 (II), 25+/-6 (ID), and 25+/-6 (DD) years. We assessed the impact of the genotypes on endothelial function and found that the DD genotype was associated with a significant blunting in endothelial-dependent vasodilatation (forearm blood flow data are presented as mean+/-SD ratio of blood flow in response to 3 incrementally increasing doses of each vasoactive agent in the test arm to blood flow in the control arm; the comparison is between DD versus ID versus II; the P value is an expression of an overall difference by ANOVA, and the 95% CIs are of a pairwise comparison between genotypes): acetylcholine, 2.88+/-1.45 versus 3.81+/-1.93 versus 4.23+/-2.37 (P=0.002; 95% CI [II versus ID], -0.19 to 0.91; 95% CI [II versus DD], 0.36 to 1.80; 95% CI [ID versus DD], 0.02 to 1.42). There was also a significant difference with the endothelial-independent vasodilator sodium nitroprusside, with values of 2.11+/-1.00 versus 2.55+/-1.36 versus 2.75+/-1.18 (P

    AB - A polymorphism within the angiotensin-converting enzyme (ACE) gene may increase the risk of myocardial infarction in individuals previously thought to be at low cardiovascular risk. The mechanism through which it exerts this effect is unknown but may be due to increased angiotensin II-induced nitric oxide (NO) breakdown and/or reduced bradykinin-mediated NO release. We investigated whether endothelial function was different between different ACE genotypes. We performed a cross-sectional study comparing the endothelial function of the 3 genotypes (II: n=25; ID: n=31; DD: n=12). Mean+/-SD ages of the subjects were 24+/-4 (II), 25+/-6 (ID), and 25+/-6 (DD) years. We assessed the impact of the genotypes on endothelial function and found that the DD genotype was associated with a significant blunting in endothelial-dependent vasodilatation (forearm blood flow data are presented as mean+/-SD ratio of blood flow in response to 3 incrementally increasing doses of each vasoactive agent in the test arm to blood flow in the control arm; the comparison is between DD versus ID versus II; the P value is an expression of an overall difference by ANOVA, and the 95% CIs are of a pairwise comparison between genotypes): acetylcholine, 2.88+/-1.45 versus 3.81+/-1.93 versus 4.23+/-2.37 (P=0.002; 95% CI [II versus ID], -0.19 to 0.91; 95% CI [II versus DD], 0.36 to 1.80; 95% CI [ID versus DD], 0.02 to 1.42). There was also a significant difference with the endothelial-independent vasodilator sodium nitroprusside, with values of 2.11+/-1.00 versus 2.55+/-1.36 versus 2.75+/-1.18 (P

    U2 - 10.1161/01.hyp.33.5.1164

    DO - 10.1161/01.hyp.33.5.1164

    M3 - Article

    VL - 33

    SP - 1164

    EP - 1168

    JO - Hypertension

    JF - Hypertension

    SN - 0194-911X

    IS - 5

    ER -